Akanda (AKAN) Notes Payables (2022 - 2025)
Akanda (AKAN) posted quarterly Notes Payables of $1.0 million for Q4 2025, up 185.4% year-over-year from $352814.0 in Q4 2024, and up 446.39% quarter-over-quarter from $184285.0 in Q2 2025.
Akanda (AKAN) Notes Payables (2022 - 2025) Analysis & Trends
Akanda's Notes Payables history runs 4 years deep, the most recent figure standing at $1.0 million for Q4 2025.
- In Q4 2025, Notes Payables rose 185.4% year-over-year to $1.0 million; the TTM figure through Dec 2025 stood at $1.0 million (up 185.4% YoY), while the FY2025 annual figure was $1.0 million, up 185.4% from the prior year.
- Notes Payables for Q4 2025 stood at $1.0 million, up from $184285.0 in the prior quarter.
- The five-year high for Notes Payables was $1.0 million in Q4 2025, with the low at $184285.0 in Q2 2025.
- The 4-year median for Notes Payables is $614801.0 (2023), against an average of $618402.3.
- The sharpest annual moves came in 2024 and 2025: Notes Payables sank 59.68% in 2024, then jumped 185.4% in 2025.
- Akanda's Notes Payables stood at $936793.0 in 2022, then fell by 6.59% to $875016.0 in 2023, then tumbled by 59.68% to $352814.0 in 2024, then jumped by 185.4% to $1.0 million in 2025.
- Business Quant data shows AKAN's Notes Payables at $1.0 million in Q4 2025, $184285.0 in Q2 2025, and $352814.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Akanda | 267,380.78 | 267,380.78 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.01 Mn |
| Jun 30, 2025 | 184,285.00 |
| Dec 31, 2024 | 352,814.00 |
| Jun 30, 2024 | 354,586.00 |
| Dec 31, 2023 | 875,016.00 |
| Dec 31, 2022 | 936,793.00 |